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Abstract We clinically assessed and
performed polymerase chain reaction
analysis for the GAA trinucleotide
repeat expansion in 103 patients from
73 families in Ireland, with a prior
clinical diagnosis of Friedreich’s
ataxia (FA) or an unclassified pro-
gressive ataxic syndrome. The pa-
tients were classified as “typical” or
“atypical” FA according to Harding’s
mandatory clinical diagnostic crite-
ria. All patients underwent blood glu-
cose analysis, and electrocardiogra-
phy and echocardiography was
performed in 99 and 101 patients, re-
spectively. Mutation screening for
expanded CAG trinucleotide repeats,
associated with spinocerebellar
ataxia (SCA) 1, 2, 3 and 6 was per-
formed in 86 patients overall, includ-
ing all GAA negative patients. Forty-
nine of 56 typical patients and 13 of
47 atypical patients were either ho-
mozygous or heterozygous for the
GAA expansion. Seven patients with
a typical FA phenotype were negative
for the GAA expansion. Although
one of these patients had vitamin E
deficiency, and two had raised α-feto-
protein levels, three other GAA nega-
tive patients with a typical FA pheno-
type had no other identifiable cause
for their ataxia, once again raising
the possibility of locus heterogeneity
in FA. It is also possible that these
patients have two point mutations in
the X25 gene, or that they have an-
other ataxic syndrome mimicking the
FA phenotype. Two families who
were homozygous for the GAA ex-
pansion exhibited intrafamilial phe-
notypic variability. Only one GAA
negative patient had the SCA 3 muta-
tion, and this was the only patient in
the study with a possible autosomal
dominant inheritance pattern. In the
homozygous GAA population typical
patients had significantly more re-
peats on the smaller allele than atypi-
cal patients, and there was an inverse
relationship between the number of
repeats on the smaller allele and the
age at presentation. There was also
an inverse relationship between the
repeat size on both the larger and the
smaller of the two alleles and the age
at becoming wheelchair bound. There
was no significant relationship be-
tween repeat size and the other in-
dices of disease severity, including
the presence or absence of diabetes
or cardiomyopathy. This is the first
large study of an Irish population
with progressive ataxia that has
shown a similar phenotype/genotype
relationship to studies of FA in other
European and non-European popula-
tions. The relatively low sensitivity
and specificity of Harding’s clinical
diagnostic criteria must be appreci-
ated when clinically assessing pa-
tients with a progressive ataxic syn-
drome. Although molecular genetic
analysis now plays an essential role
in diagnosis and classification, pa-
tients with a typical FA phenotype
without any identifiable cause for
their ataxia exist.
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Introduction
In 1981, Harding [1] studied 115 patients with Friedreich’s
ataxia (FA) and proposed what are commonly known as
“Harding’s” criteria for the clinical diagnosis of this auto-
somal recessive syndrome [1]. The mandatory clinical di-
agnostic criteria which emerged from this landmark study
include: (a) an age at onset below 25 and definitely below
27 years, (b) ataxia of all four limbs, (c) ataxia of gait, (d)
lower limb areflexia and (e) presumed or proven autosomal
recessive inheritance. The frequency of other findings such
as dysarthria, extensor plantar responses, abnormal lower
limb vibration sensation and joint position sensation varied
depending on the duration of the disease. Although con-
sidered important “secondary diagnostic criteria” for entry
into Harding’s study, dysarthria was noted in only 60% of
patients 5 years after disease onset, and extensor plantar re-
sponses in only 88.7% of patients overall.
Subsequent to the identification of a GAA trinucleotide
repeat expansion in the first intron of the X25 gene on chro-
mosome 9q13–21.1 [2], interest in the relationship be-
tween the genotype and the severity of the phenotype of FA
has been kindled. Several studies have established that nor-
mal chromosomes contain 7–29 GAA repeats, whereas FA
chromosomes carry between 66–1700 [2–7]. Campuzano
et al. [2] studied 79 patients with “typical” FA (criteria not
specified in the report) and found that 71 were homozygous
and 8 patients were heterozygous for the GAA expansion.
In light of this genetic information, the sensitivity and
specificity of the clinical diagnostic criteria of Harding [1]
and Geoffrey et al. [8] have come under scrutiny. To assess
the relationship between the phenotype and genotype of FA,
we performed an observational analytical study on 103 pa-
tients from 73 families in Ireland, with a prior clinical diag-
nosis of FA or an unclassified progressive ataxic syndrome.
We also assessed the sensitivity and specificity of Harding’s
diagnostic criteria for identifying patients who were het-
erozygous or homozygous for the GAA expansion.
Patients and methods
Patients were included in the study if they had a prior clinical diag-
nosis of FA or an unclassified progressive ataxic syndrome estab-
lished by their neurologist or consultant physician. The age at disease
onset was not specified as an inclusion or exclusion criterion. The
vast majority of patients were referred for assessment by the Fried-
reich’s Ataxia Society of Ireland, with a smaller proportion referred
by consultant neurologists in the Republic of Ireland. A detailed his-
tory, including family history, was taken, and each patient was as-
sessed clinically by one of the authors [D. J. H. M. (n=82), R. P. M.
(n=16) or M.K (n=5)] using a standardised protocol based on the
Kurtzke Functional Systems Neurological Examination [9]. One pa-
tient was Chinese, the genealogy of one patient was unknown, and
one patient was the offspring of a Romanian mother and an Irish fa-
ther. The parents of the remaining 100 patients were Irish. “Typical”
patients had to fulfil all of Harding’s mandatory diagnostic criteria,
including a pattern of inheritance consistent with an autosomal re-
cessive disorder. Due to the absence of dysarthria and extensor plan-
tar responses in a significant proportion of patients in Harding’s orig-
inal series, these criteria were not considered to be “mandatory” for
the diagnosis. The remaining patients were classified as having
“atypical” FA, as were those with ophthalmoparesis or ophthalmo-
plegia, because horizontal or vertical gaze palsy and external oph-
thalmoplegia were not included in classical descriptions of the dis-
ease at the outset of the study.
The indices of severity used to assess the relationship between the
phenotype and genotype of the disease included: age at onset of the
disease; duration to assistance to walk; duration to becoming wheel-
chair-bound; age at becoming wheelchair-bound; and presence or ab-
sence of diabetes, cardiomyopathy or retained deep tendon reflexes.
Age at onset was defined as the age at which the first neurological
symptom was noted, and disease duration refers to the duration be-
tween the age at onset and the age at examination. Duration to assis-
tance to walk refers to the duration in years from the onset of the dis-
order until requiring permanent assistance to walk (permanently
requiring either a stick or walking aid or the assistance of another
person to walk). Age at becoming wheelchair-bound was defined as
the age when the patient was permanently dependent on a wheel-
chair, and duration to becoming wheelchair-bound refers to the dif-
ference in years between the age at onset and the age at becoming
wheelchair-bound.
Random blood glucose was measured in all patients and, if ele-
vated, a fasting and 2-h post-prandial assay was performed. Patients
were considered to be diabetic if they had a definite prior diagnosis
or a fasting blood glucose greater than 6.7 mmol/l. Electrocardiogra-
phy (ECG) and two-dimensional transthoracic echocardiography
(ECHO) was performed in 99 and 101 patients, respectively. Current
ECGs were unavailable on one sibling pair, and the abnormalities
noted on their recordings in 1982 were therefore used, but otherwise
all ECGs were performed at the time of assessment. Each ECG was
classified as normal or abnormal by a consultant cardiologist
(D. P. M.), who was blinded to the clinical categorisation and molec-
ular genetic status of the patients. The ECHOs were evaluated by the
same cardiologist for changes of concentric left ventricular hyper-
trophy, non-concentric left ventricular hypertrophy, asymmetrical
septal hypertrophy, dilated cardiomyopathy, valvular defects and
other detailed indices of cardiac function. One patient with a possi-
ble autosomal dominant inheritance pattern subsequently had a tran-
soesophageal echocardiogram to confirm the results of the transtho-
racic ECHO.
Polymerase chain reaction (PCR) analysis for the GAA trinu-
cleotide repeat expansion was performed in all patients and screen-
ing for spinocerebellar ataxia (SCA) 1, 2, 3 and 6 mutations was per-
formed in 86 patients, including all those who were GAA negative.
Genomic DNA was extracted from peripheral blood lymphocytes us-
ing a standard salting out procedure [10]. To estimate the size of the
GAA repeat in intron 1 of the frataxin (X25) gene, PCR was per-
formed on DNA samples using the following primers: GAA–104F:
5-GGCTTAAACTTCCCACACGTGTT and GAA–629R: AG-
GACCATCATGGCCAC ACTT [4] with the Boehringer-Mannheim
Long Template PCR system. PCR conditions were 94°C for 2 min,
17 cycles at 94°C for 10 s, 68°C for 2 min 30 s followed by 20 cycles
of 94°C for 10 s, 68°C for 2 min 30 s with the addition of 20 s to the
extension time per cycle, and a final extension at 68° for 10 min. This
generates a PCR product of (500+3n) base pairs, where n is the num-
ber of GAA repeats. The size of the PCR product was estimated us-
ing appropriate size standards (Gibco BRL) and the Phoretix one-di-
mensional programme (Phoretix International). Screening for SCA
1, 2, 3 and 6 mutations was performed by published methods
[11–14].
In typical patients who were negative for the GAA expansion,
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levels of vitamin E [15, 16] and hexosaminidase A [17] were mea-
sured to exclude deficiency states that can produce an ataxic syn-
drome resembling FA. We also measured α-fetoprotein levels and
performed preliminary cytogenetic analysis to look for consistent
numerical or structural abnormalities in G-banded metaphases iden-
tified in ataxia telangiectasia. In addition, we performed lipoprotein
electrophoresis to exclude abetalipoproteinaemia or hypobeta-
lipoproteinaemia, mutation screening for hereditary motor and sen-
sory neuropathy (HMSN) I, and measured the amplitude of the sural
sensory nerve action potential (SNAP) and the median nerve motor
conduction velocity (MCV) [1].
Simple linear regression was used to explore the relationship be-
tween selected continuous variables, and the resulting regression
models are illustrated in the text where appropriate. The t test was
used for comparison of group means, and cross-tabulation methods
were used for screening of patient characteristics.
Results
Within our study population of 103 patients, 67 had a pos-
itive family history of an autosomal recessive ataxic syn-
drome, 35 had a sporadic ataxic syndrome with no other
family members affected, and one patient had an ataxic
syndrome of presumed autosomal dominant inheritance.
The parents of three affected siblings were possibly fifth or
sixth cousins, and one sib pair had parents who were third
cousins; otherwise, a history of consanguinity was not
elicited.
There were 56 men and 47 women, with a mean age at
onset of 11.2 years (range: 1–54 years) and a mean age at
examination of 31.2 years (range: 11.5–71 years). The old-
est patient (age at onset 54 years and age at examination
71 years) was found to have a history of excessive alcohol
consumption on assessment at our clinic and was consid-
ered to have an alcohol-related ataxic syndrome.
Categorisation of the study population according to
phenotype revealed 56 typical and 47 atypical patients. The
results of the molecular genetic analysis on these two
groups are summarised in Table 1.
Within the homozygous population (those with ex-
panded repeats on each allele; n=58) the mean GAA repeat
length for the larger of the two alleles (GAA 1) was 885
(range 534–1200) and for the smaller of the two alleles
(GAA 2) was 762 (range 333–1053). A sample agarose gel
obtained from the patients in the study is shown in Fig. 1.
The frequency of the predominant clinical characteris-
tics of the phenotype/genotype subgroups are summarised
in Table 2.
Typical homozygotes
Within the typical homozygous subgroup (n=47), ataxia of
gait was the presenting symptom in 80.9% of patients and
was present in all patients on examination. The incidence
of dysarthria, extensor plantar responses and abnormal
lower limb joint position sensation was similar to that ob-
served in Harding’s series, whereas scoliosis (91.5%), ab-
normal lower limb vibration sensation (89.4%), pes cavus
(80.9%) and hearing abnormalities (22.4%) were more
frequent. Nystagmus was noted in 80.9% of patients in this
subgroup compared to only 20% of patients in Harding’s
series. However, the nystagmus was only mild, often not
sustained, and gaze-evoked on horizontal or vertical gaze
in 45%, moderate in 30% and severe in 6% of patients on
examination. If one excludes patients with only mild nys-
tagmus which may not have been pathological, the fre-
quency of this finding falls to 36% which is similar to the
incidence of nystagmus reported in other recent studies in
the literature [3, 7]. Only moderate or severe nystagmus
was considered when calculating the frequency of this find-
ing in the other phenotype/genotype subgroups. An unex-
pectedly large percentage of patients had titubation
(45.7%) and abnormal lower limb superficial sensation
(50%). The latter was defined as reduced or increased ap-
preciation of light touch, pin-prick or temperature sensa-
tion. None of these patients were diabetic, and peripheral
cyanosis was identified in only four of the 23. Diabetes was
less common (6.5%) and optic atrophy or suspicious optic
disc pallor was noted in only 6.4% of typical homozygotes
in comparison to 30.4% of Harding’s patients.
All patients in this category had abnormalities on their
ECG, and ECHO was abnormal in 32 of 46 typical ho-
mozygotes (69.6%). Concentric left ventricular hypertro-
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Table 1 Phenotype vs. molecular genetic status: absolute number of
patients in each group (GAA HOMO GAA expansions identified on
both alleles, GAA hetero GAA expansion identified on one allele
only, GAA Neg no GAA expansion identified)
Phenotype Total GAA Homo GAA Hetero GAA Neg
Typical FA 56 47 2 7
Atypical FA 47 11 2 34
Fig. 1 1.5% agarose gel showing PCR amplification products from
X25 intron 1 GAA repeat expansions. M Size marker (sizes shown
in base pairs).
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phy was the commonest abnormality on ECHO (37%),
followed by asymmetrical septal hypertrophy (19.6%) and
non-concentric left ventricular hypertrophy (13%). Di-
lated cardiomyopathy was present in one patient (2.2%)
who also had features of concentric left ventricular hy-
pertrophy.
Typical heterozygotes
The two typical heterozygous patients are presumed com-
pound heterozygotes, but to date we have identified a GAA
expansion on only one allele in each patient, estimated at
222 and 852 repeats, respectively. They are presumed to
carry a point mutation on the other allele, but mutation
screening for the I154F and G130V mutations and single-
strand conformation analysis of all five exons have so far
been negative (data not shown).
Table 2 Frequencies of clinical characteristics in the different phenotype/genotype subgroups (GAA HOMO GAA expansions identified on
both alleles, GAA hetero GAA expansion identified on one allele only, GAA Neg no GAA expansion identified, SS soft touch and/or pin
prick and/or temperature sensation)
Typical Atypical
Sign GAA Homo GAA Hetero GAA Neg GAA Homo GAA Hetero GAA Neg
(n=47) (n=2) (n=7) (n=11) (n=2) (n=34)
Optic atrophy 3/47 0/2 0/7 2/11 0/2 0/34
Suspicious optic disc pallor 0/47 0/2 3/7 3/11 1/2 7/34
Nystagmus 17/47 1/2 3/7 6/11 0/2 12/34
Broken-up pursuit eye movements 27/46 1/2 3/7 3/11 0/2 8/34
Broken-up saccades 18/45 1/2 3/7 5/11 0/2 4/33
Dysarthria 43/47 2/2 5/7 11/11 1/2 24/34
Head tremor 21/46 0/2 2/7 2/11 0/2 7/34
Gait Ataxia (or not testable due to weakness) 47/47 2/2 7/7 11/11 2/2 30/33
Pyramidal weakness
Upper limbs 23/47 1/2 3/7 6/11 0/2 10/34
Lower limbs 40/47 2/2 6/7 2/11 1/2 15/34
Distal weakness
Upper limbs 3/47 1/2 0/7 1/11 1/2 3/34
Lower limbs 8/46 0/2 4/7 2/11 1/2 7/34
Areflexia
Upper limbs 42/47 2/2 6/7 5/11 0/2 8/34
Lower limbs 47/47 2/2 7/7 3/11 0/2 8/34
Extensor plantar response 43/47 1/2 3/7 11/11 1/2 14/34
Abnormal vibration sensation
Upper limbs 21/47 2/2 5/7 2/10 2/2 8/32
Lower limbs 42/47 2/2 6/7 9/10 2/2 13/32
Abnormal joint position sensation
Upper limbs 25/45 1/2 4/7 3/10 0/2 2/33
Lower limbs 38/45 1/2 6/7 9/10 1/2 10/32
Abnormal SS
Upper limbs 13/47 0/2 0/7 1/10 1/2 3/33
Lower limbs 23/46 1/2 2/7 8/10 2/2 8/33
Distal amyotrophy
Upper limbs 15/47 0/2 2/7 2/11 1/2 5/34
Lower limbs 31/47 0/2 4/7 8/11 1/2 9/34
Scoliosis 43/47 1/2 1/7 6/11 1/2 10/34
Pes Cavus 38/47 1/2 5/7 8/11 0/2 11/34
Diabetes 4/47 0/2 0/7 0/11 0/2 2/34
Abnormal ECG 45/45 0/1 3/6 11/11 2/2 13/34
Abnormal ECHO 32/46 0/2 0/6 6/11 1/2 5/34
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described in FA; one of these patients had raised α-feto-
protein levels and another had reduced vitamin E levels.
None had evidence of cardiomyopathy on ECHO, as de-
scribed in FA to date [20, 21].
Atypical negative patients
Within the atypical subgroup the majority (34/47) did not
have expanded GAA repeats. One of these patients, who
originated from Hong Kong, had an expanded CAG repeat
in the SCA 3 gene on chromosome 14q32.1. He first de-
veloped left lower limb ataxia and weakness at 39 years of
age, with mild dysarthria a year later, and was the only pa-
tient in the study with a history consistent with an autoso-
mal dominant ataxic syndrome. His mother developed
ataxia and dysarthria at 40 years of age, and his sister had
a history of “unsteadiness” beginning at 35 years of age. He
did not have linguofacial fasciculations, dystonia or ex-
trapyramidal features at the time of examination. None of
the remaining GAA negative patients exhibited the SCA 1,
2, 3 or 6 mutations. One atypical negative female patient
had a low vitamin E level (0.7 mg/100 ml; normal range
0.9–1.6), in addition to cerebellar vermian atrophy and
mild atrophy of the mid-brain and pons on magnetic reso-
nance imaging; she had subjectively stabilised on 400 mg
oral vitamin E daily. Vitamin E levels are not available on
any other atypical negative patients, as this was not part of
our study protocol.
Ataxia of gait was also the commonest presenting
symptom (61.8%) in this subgroup. These patients were
classified as atypical for the following reasons: 76.5% had
retained deep tendon reflexes in the legs, 14.7% had an age
at onset greater than 25 years, 14.7% did not have ataxia of
all four limbs, and gait ataxia was absent in 8.8% of pa-
tients on examination. Dysarthria (70.6%), extensor plan-
tar responses (41.2%), pes cavus (32.4%) and scoliosis
(29.4%) occurred less frequently than in Harding’s origi-
nal series, whereas nystagmus was more commonly ob-
served (35.3%). Abnormalities compatible with those re-
ported in FA were seen on the ECG in 38.2% and
concentric left ventricular hypertrophy on ECHO was re-
ported in 14.7%.
Atypical homozygotes
11 homozygous patients were excluded from the typical
category for failing to fulfil all of Harding’s mandatory di-
agnostic criteria. Seven had retained deep tendon reflexes
alone; one had a late age at onset (28 years) and exhibited
534 and 333 repeats on GAA 1 and GAA 2 respectively;
one patient had both retained reflexes and an age at onset
at 29 years, and exhibited 662 repeats on GAA 1 and GAA
2. Two patients in this group had abnormalities of eye
movement (one had moderate abduction weakness bilater-
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Typical negative patients
The clinical details of the seven typical patients who had
GAA repeats within the normal range are outlined in
Table 3. By definition these patients fulfilled all of Hard-
ing’s mandatory diagnostic criteria [1], but it is noteworthy
that three of these patients were still not wheelchair-bound
40, 25 and 22 years after disease onset. One patient pre-
sented with titubation, and another with “leg spasms”,
which are uncommon presenting symptoms of typical FA
[1]. Patient 1 had choreiform movements of the hands and
face, which has been previously described in FA [18], and
is still ambulatory with assistance at 48 years of age. Nerve
conduction studies revealed a severe sensory axonal neu-
ropathy with a median nerve MCV of 42 m/s. Patient 6 also
had choreiform movements of the hands and face with an
absent sural SNAP and a markedly reduced median nerve
MCV of 32.3 m/s. He has a 25-year-old atypical GAA neg-
ative sister, who was classified as atypical purely due to a
left lateral rectus palsy. Her disease course was more rapid,
and she became wheelchair-bound at age 19; her sural
SNAP was absent also with a median nerve MCV of 45.4
m/s. These three patients had elevated α-fetoprotein levels,
but vitamin E, hexosaminidase A levels and lipoprotein
electrophoresis were normal, and preliminary cytogenetics
for ataxia telangiectasia, and mutation screening for
HMSN I was negative. None of these patients had any ap-
parent telangiectasia, but it is possible that they have ataxia
telangiectasia mimicking the typical FA phenotype in two;
further screening for the genetic defect associated with
ataxia telangiectasia is in progress. It is of interest that two
of these patients had peripheral nerve conduction studies
compatible with typical FA [1]. Patient 3 had a talipes equi-
nus deformity of both feet and was noted to be ataxic while
walking at 2 years of age. His nerve conduction studies
were compatible with the predominantly sensory axonal
neuropathy described in FA. His sister also has an early-on-
set ataxic syndrome, but in addition she has a history of de-
velopmental delay, learning disability, short stature, pig-
mentary retinopathy and a short PR interval on ECG and is
negative for the GAA trinucleotide repeat expansion. Pa-
tient 5 had normal cardiac findings but had nerve conduc-
tion studies consistent with typical FA also. Patient 7 has a
59-year-old brother in the atypical GAA negative category
who has a more slowly progressive disease course with re-
tained deep tendon reflexes, and he did not become wheel-
chair-bound until 38 years after disease onset. Patient 7 had
normal nerve conduction studies and both siblings had re-
duced vitamin E levels with normal biochemical and ge-
netic screening tests otherwise. Screening for a mutation in
the α-tocopherol transfer protein on chromosome 8q13,
which may cause autosomal recessive ataxia with vitamin
E deficiency [19], is underway in this sib pair. Patient 2 re-
fused to have further tests performed to look for an alter-
native cause for his ataxia. Four patients in this subgroup
had abnormalities on their ECG compatible with changes
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Table 3 Typical/GAA negative (SS soft touch and/or pin prick and/or temperature sensation, AOG = ataxia of gait z, ULA = upper limb
ataxia, NIA = not applicable)
Sign Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7
Gender Male Male Male Male Male Male Male
Age at presentation 8 years 1 year 2 years 17 years 2 years 6 years 8 years
Presenting symptom Titubation AOG AOG Leg spasms AOG AOG ULA
Disease duration 40 years 63 years 22 years 25 years 11 years 30 years 40 years
Duration to
assistance to walk 32 years 15 years 16 years 24 years N/A 21 years 12 years
Duration to being
wheelchair-bound N/A 26 years N/A N/A N/A 23 years 12 years
Scoliosis No No Yes No No No Yes
Pes cavus Yes R, L Yes R No Yes R, L No Yes R, L Yes R, L
High medial arches N/A N/A Yes R, L N/A Yes R, L N/A N/A
Suspicious optic disc Yes Yes No No Yes No No
pallor
Choreo-athetosis Hands, face No No No No Hands, face No
Titubation Yes No No No No No Yes
Nystagmus Yes Yes No Yes No Yes Yes
Dysarthria Moderate Severe No No Mild Mild Severe
Limb tone Hypotonic Hypotonic Spastic Hypotonic Normal Normal Hypotonic
Distal amyotrophy Legs Arms, legs Legs No No Arms, legs No
Pyramidal weakness Moderate legs Severe arms, No Mild right Moderate Moderate Mild arms,
moderate legs arm, moderate legs legs moderate legs
legs
Distal weakness No Severe legs Severe legs No No Severe legs Severe legs
Areflexia arms Yes Yes Yes Yes Yes Yes Normal
biceps, triceps
Areflexia legs Yes Yes Yes Yes Yes Yes Yes
Plantar response Equivocal Equivocal Equivocal/up Up Absent Equivocal Up
Ataxia arms Moderate Severe Mild Mild Mild Moderate Moderate
Ataxia legs Moderate Wheelchair Moderate Moderate Moderate Severe Wheelchair
bound bound
Ataxia of gait Severe Severe Severe Moderate Moderate Severe Severe
Abnormal vibration
sensation
Upper limbs No Yes Yes Yes Yes Yes No
Lower limbs Yes No Yes Yes Yes Yes Yes
Abnormal joint
position sensation
Upper limbs No Yes Yes Yes Yes No No
Lower limbs No Yes Yes Yes Yes Yes Yes
Abnormal SS.
lower limbs No No No Yes No Yes No
ECG Normal N/A Right axis Borderline Normal Right axis Short PR
deviation left atrial deviation interval
hypertrophy
ECHO Normal N/A Normal Mildly Normal Normal Normal
impaired LV
diastolic
function
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ally, and one had mild limitation of upgaze bilaterally), but
were otherwise typical in all respects. This latter patient,
with restricted upgaze, exhibited 1144 and 869 repeats on
GAA 1 and GAA 2 respectively, and had a typical brother
with 924 and 731 GAA repeats. Two brothers in this sub-
group, aged 25 and 27 years, had retained upper and lower
limb reflexes, and PCR testing revealed that one had 571
and the other 626 repeats on GAA 2. They had a typical ho-
mozygous areflexic brother (aged 34 years) who had 879
repeats on GAA 2, confirming previous reports of intrafa-
milial phenotypic variability in FA [22].
Atypical heterozygotes
The two patients in this category are interesting. One pa-
tient has had a very slowly progressive disease course be-
ginning at 10 years of age, with minimal ataxia and pro-
found lower limb spasticity. He had 954 expanded GAA
repeats on one allele and a G130V mutation on the other.
The second patient is the father of two typical homozygous
affected sons, and some of the details of this pedigree with
possible pseudo-dominant inheritance have been outlined
previously [23].
We were able to use microsatellite markers in and
around the FA locus to investigate inheritance in five pairs
of clinically affected siblings (including the three typical
negative patients with atypical siblings), and one set of four
atypical GAA negative female siblings. In two sib pairs
with atypical FA, involvement of the FA locus was ex-
cluded. In the three sib pairs with one typical and one atyp-
ical patient in each, involvement of the FA locus was ex-
cluded in one pair (patient 3). However, alleles were shared
in the two sib pairs with raised α-fetoprotein levels and vi-
tamin E deficiency respectively. In the sibship of four af-
fected sisters, two sibs shared alleles at all loci tested,
whereas involvement of the FA locus was excluded in the
other two (data not shown).
Phenotype/genotype relationship 
in the homozygous population
Within the homozygous population, there was an inverse
relationship between the repeat size on GAA 2 and the age
at onset of the disorder (P=0.03). There was also a signifi-
cant inverse relationship between repeat size on both GAA
1 (P=0.0009) and GAA 2 (P=0.01) and the age at becom-
ing wheelchair-bound. Otherwise, there was no significant
relationship between the GAA repeat size on either allele
and the other indices of disease severity (Table 4).
Typical homozygous patients as a group had signifi-
cantly more repeats on GAA 2 than atypical patients
(793±19.7 vs. 642±38.6, P=0.001). Because all homozy-
gotes had abnormalities on their ECG, it was not possible
to compare the mean repeat size between patients who did
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and those who did not have features of cardiomyopathy on
the ECG. There was no significant difference in the mean
repeat length on GAA 1 or GAA 2 between patients who
did and those who did not have cardiomyopathy overall on
ECHO. However, subgroup analysis revealed that 6 pa-
tients with non-concentric left ventricular hypertrophy on
ECHO had significantly more repeats on GAA 1 than the
51 patients without non-concentric left ventricular hyper-
trophy (985 vs. 874, P=0.04; two-sample t test assuming
unequal variance). Due to the unbalanced nature of these
samples this statistically significant result may not be truly
representative of the FA population as a whole, and its clin-
ical significance is debatable. There was no significant dif-
ference in repeat size between patients who did and those
who did not have concentric left ventricular hypertrophy,
asymmetrical septal hypertrophy or dilated cardiomyopa-
thy.
Comparison of mean GAA repeat lengths on the two al-
leles between patients with and without diabetes did not re-
veal any significant differences between the subgroups
(GAA 1, P=0.6; GAA 2, P=0.26: two-sample t test, as-
suming unequal variance). However, the low incidence of
diabetes in this study (4 diabetic vs. 54 non-diabetic ho-
mozygotes) did not facilitate a clinically representative re-
sult either. Within the homozygous group there was no sig-
nificant difference in the number of expanded repeats
between patients with and without areflexia (GAA 1,
P=0.55; GAA 2, P=0.21).
The sensitivity of Harding’s clinical diagnostic criteria
for identifying patients who were GAA positive was 79%
(49/62). The specificity of these criteria for identifying pa-
tients who were GAA negative was also relatively low at
83% (34/41).
Table 4 Regression relationship between the repeat size on GAA 1
and GAA 2 and the indices of severity of FA (AP age at onset of the
disease, AWB age at becoming wheelchair-bound, DTA duration to
assistance to walk, DTW duration to becoming wheelchair-bound)
Slope t P R2
of line
GAA 1 vs. AP (n=56) –4.920 –1.38 0.17 0.034
GAA 2 vs. AP (n=56) –9.460 –2.18 0.03 0.081
GAA 1 vs. AWB (n=42) –7.767 –3.58 0.0009 0.243
GAA 2 vs. AWB (n=42) –7.604 –2.66 0.01 0.151
GAA 1 vs. DTA (n=50) –2.043 –0.36 0.72 0.003
GAA 2 vs. DTA (n=50) –1.556 –0.23 0.82 0.001
GAA 1 vs. DTW (n=42) –4.984 –1.33 0.19 0.043
GAA 2 vs. DTW (n=42) –6.196 –1.33 0.19 0.043
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sensation in 78.3% and 73% respectively, and pes cavus
in 54.9% of patients [1]. The plantar responses were ex-
tensor in 88.7%, absent in 10.4% and flexor in 0.9% of
Harding’s patients. Therefore none of these findings were
universal, and their absence should not warrant the exclu-
sion of these patients from the typical category. However,
it is unusual that two of the typical negative patients did
not have dysarthria at 22 and 25 years after disease onset.
Three patients in the typical negative subgroup had sib-
lings who were classified as atypical. In this study and in
another recent report [22], families have been identified
containing some homozygous members exhibiting the typ-
ical phenotype and others with preserved or exaggerated
reflexes. This confirms that intrafamilial phenotypic vari-
ability exists in FA, and a family history of an atypical sib-
ling should not rule out the possibility of typical FA in an-
other sibling. Conversely, the identification of intrafamilial
phenotypic variability should alert one to the possibility of
another inherited ataxic syndrome, and further tests in-
cluding vitamin E, hexosaminidase A and α-fetoprotein
levels etc. should be measured if mutation screening for
the GAA expansion is negative. One typical negative pa-
tient had an atypical GAA negative sister whose pheno-
type was inconsistent with classic FA, and although un-
likely, it is possible that these siblings are affected by two
distinct ataxic syndromes. This theory is supported by the
exclusion of involvement of the FA locus on microsatel-
lite analysis in this sib pair. However, it is more probable
that they have phenotypic variations of a recessive ataxic
syndrome distinct from but mimicking FA in the brother.
Four typical negative patients had abnormalities on their
ECG that have been described in FA, and one had mildly
impaired left ventricular diastolic function on ECHO. Al-
though features of cardiomyopathy on ECG or ECHO sup-
port a clinical diagnosis of FA even with negative PCR re-
sults, these findings are not specific for FA because
cardiomyopathy has been described with vitamin E defi-
ciency also [25]. At least three patients in the typical neg-
ative category could have two point mutations in the X25
gene, although this has never been described to date. It is
possible, as suggested by others [7, 26], that there is locus
heterogeneity in FA, and that there is another, as yet
unidentified, mutation causing clinical FA. Locus hetero-
geneity was investigated using microsatellite markers
closely linked to the FA locus. This analysis can exclude
the involvement of the identified FA locus (if alleles are
not shared), but cannot prove involvement, because one in
four siblings will share alleles by chance. This is illus-
trated by the finding of shared alleles in two sib pairs, one
with vitamin E deficiency and one with possible ataxia
telangiectasia. We were able to exclude FA in three of six
families tested and to provide strong evidence for exclu-
sion in a fourth sibship. This approach is useful when fam-
ilies suspected of having FA are found to be GAA expan-
sion negative, before extensive screening for double point
mutations is undertaken.
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Discussion
In this study we assessed 103 patients with a progressive
ataxic syndrome, and with the exception of only one, all
had a history consistent with an autosomal recessive disor-
der. One hundred patients were of definite Irish descent,
and this is the first large phenotype/genotype study of pro-
gressive ataxia in this genetically homogeneous European
population. We strictly applied Harding’s mandatory diag-
nostic criteria, as outlined above, in classifying patients as
typical or atypical. This contrasts with other papers on this
topic that included extensor plantar responses [3, 7, 24],
dysarthria [7], and sensory axonal neuropathy [5] as es-
sential diagnostic criteria for typical FA. Despite specify-
ing these criteria, Dürr et al. [3] included ten patients in the
typical group who did not have extensor plantar responses,
including two who had intact lower limb reflexes. Cam-
puzano et al. [2] did not specify the diagnostic criteria for
typical patients at all, and Filla et al. [4] and Monrós et al.
[5] classified patients as typical if their age at onset was be-
low 20 years of age. Lamont et al. [23] studied 56 patients
who fulfilled Harding’s diagnostic criteria for FA (with the
exception that no upper age limit was set and areflexia was
not essential), and all were homozygous for the GAA tri-
nucleotide repeat expansion.
These differences in the criteria used to classify patients
may in part be responsible for the reported variability in the
percentage of typical patients harboring the GAA expan-
sion in different series. If the presence of at least one GAA
expansion is taken as a requirement for the diagnosis of FA,
Harding’s criteria identified only 47 out of a total of 62
GAA positive patients as having typical FA. This yields a
relatively low diagnostic sensitivity of 79% for the clinical
diagnostic criteria in this study. This contrasts with the
100% clinical diagnostic sensitivity in several series [2, 5,
6, 23], but compares favourably with a sensitivity of 76.3%
and 75.8% in the studies by Schöls et al. [7] and Dürr et al.
[3] (despite variable application of the criteria by the latter
group). We identified two affected homozygous siblings,
one of whom was typical and the other was classified as
atypical due to mild reduction in upgaze bilaterally. Dürr et
al. [3] recorded “limited eye gaze with preserved vestibulo-
ocular movements” in five homozygous patients also.
Therefore, in the absence of other significant variables, eye
movement abnormalities should no longer exclude patients
from the typical category.
The specificity of Harding’s clinical diagnostic criteria
in this study was also relatively low at 83%, due to the
seven GAA negative patients who fulfilled all of the
mandatory criteria for typical FA. Within this subgroup,
patient 1 was still not wheelchair-bound at 48 years of age.
Although outside the mean age range of 25.14±15.5 years,
he is still within the overall age range for becoming wheel-
chair-bound of 11–58 years [1]. In the original series of
patients dysarthria was recorded in 96.5%, scoliosis in
79.1%, abnormal lower limb joint position and vibration
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We identified 11 atypical patients who were homozy-
gous for the GAA expansion. Our results confirm the sug-
gestions of previous authors [27, 28] that the clinical spec-
trum of FA extends to include patients with retained deep
tendon reflexes and late-onset disease. In addition, the in-
cidence of abnormal lower limb superficial sensation has
been underestimated in FA to date.
In concordance with previous reports [3–7, 23], we
found a significant inverse relationship between the GAA
repeat size on the smaller of the two alleles and the age at
presentation of the disorder. There was also a significant in-
verse relationship between repeat size on both the smaller
and larger of the two alleles and the age at becoming
wheelchair-bound. In contrast with other studies [3, 6, 7],
our results and those of Filla et al. [4] did not demonstrate
a significant relationship between repeat size and the dura-
tion to becoming wheelchair-bound. In this series GAA re-
peat size did not significantly affect the duration to assis-
tance to walk, a relationship not assessed in other studies.
Dürr et al. [3] reported that patients with cardiomyopathy
on ECHO had significantly more repeats on the smaller of
the two alleles than those without, and Filla et al. [4] re-
ported similar findings for the smaller, larger and mean
number of repeats overall. Monrós et al. [5] concluded that
patients with cardiomyopathy had larger expansions than
those without, with the difference being more significant
for the larger allele. We did not find any significant differ-
ence in the mean repeat size on the smaller or larger allele
between patients with and without cardiomyopathy on
ECHO. In this regard we confirm the findings of Monter-
mini et al. [6], although they did not specify the exact num-
ber of patients in their study who had ECHOs performed,
and their definition of cardiomyopathy differed from ours.
None of typical negative patients had diabetes mellitus, and
the overall incidence of diabetes in the homozygous popu-
lation (6.9%) was lower than previously reported by sev-
eral authors [1, 3, 4, 24], and slightly higher than in the
study by Schöls et al. [7]. The I154F mutation was not
found in any of the presumed compound heterozygotes of
Irish descent. Because all I154F cases to date are from a re-
stricted area in southern Italy [2, 4], this mutation may not
be an important cause of FA in other European or non-Eu-
ropean populations.
Thirty-four of a total of 102 patients with a presumed
autosomal recessive ataxic syndrome were GAA negative,
did not have the SCA 1, 2, 3 or 6 mutations, and to date
have no identifiable cause for their ataxia. These patients
warrant further biochemical, molecular genetic, neuro-
physiological and neuroradiological investigations to de-
termine the cause of their ataxia. If negative, linkage analy-
sis and subsequent screening of the X25 gene to identify
previously described and novel point mutations may facil-
itate a molecular genetic diagnosis in these patients, be-
cause it is possible that two point mutations could produce
a forme fruste of FA. It is more likely that these patients
have another, as yet unidentified, ataxic syndrome geneti-
cally distinct from FA.
Therefore, when assessing patients with a progressive
ataxic syndrome in a clinical setting, strict application of
Harding’s mandatory diagnostic criteria may fail to iden-
tify GAA positive patients in up to 21% of cases and may
yield a false positive clinical result in up to 17% of cases.
These results alert us to the limitations of the clinical diag-
nostic criteria, and stress the importance of molecular ge-
netic analysis for the GAA trinucleotide repeat expansion
in all patients with a presumed autosomal recessive or spo-
radic ataxic syndrome. If this is negative, it is mandatory to
search for disorders that mimic FA and to perform detailed
neurophysiological investigations to exclude HMSN type I
[1]. When counselling patients, especially those who are
GAA negative, who have been informed for years that they
have FA, it is useful to clarify their phenotypic and geno-
typic status as outlined in this study.
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